Effect of amodiaquine, a histamine N-methyltransferase inhibitor, on, Propionibacterium acnes and lipopolysaccharide-induced hepatitis in mice

Akira Yokoyama, Shuji Mori, Hideo K. Takahashi, Toru Kanke, Hidenori Wake, Masahiro Nishibori

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

We examined whether treatment with amodiaquine, a potent inhibitor of histamine N-methyltransferase protects mice from Propionibacterium acnes (P. acnes)-primed and lipopolysaccharide (LPS)-induced hepatitis. The subcutaneous injection of amodiaquine (2 and 5 mg/kg) significantly increased the histamine levels in the liver in comparison to saline treated mice. Pretreatment with amodiaquine also improved the survival rate of the hepatitis mice, and this improvement was partially associated with the decrease in serum levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT). Amodiaquine partially suppressed increases of tumor necrosis factor (TNF)-α in the serum and TNF-α mRNA expression in the liver, whereas the expression of interleukin (IL)-18, interferon (IFN)-γ and IL-12 in the liver was not changed by amodiaquine treatment. In conclusion, the present findings suggested that the elevation of endogenous histamine by amodiaquine may thus play a protective role through the regulation of TNF-α production in endotoxin-induced hepatic injury mice.

Original languageEnglish
Pages (from-to)179-184
Number of pages6
JournalEuropean Journal of Pharmacology
Volume558
Issue number1-3
DOIs
Publication statusPublished - Mar 8 2007

Fingerprint

Histamine N-Methyltransferase
Amodiaquine
Propionibacterium acnes
Hepatitis
Lipopolysaccharides
Tumor Necrosis Factor-alpha
Liver
Histamine
Interleukin-18
Subcutaneous Injections
Interleukin-12
Aspartate Aminotransferases
Serum
Alanine Transaminase
Endotoxins
Interferons
Messenger RNA
Wounds and Injuries
Therapeutics

Keywords

  • Amodiaquine
  • Hepatitis
  • Lipopolysaccharide
  • Propionibacterium acnes

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Effect of amodiaquine, a histamine N-methyltransferase inhibitor, on, Propionibacterium acnes and lipopolysaccharide-induced hepatitis in mice. / Yokoyama, Akira; Mori, Shuji; Takahashi, Hideo K.; Kanke, Toru; Wake, Hidenori; Nishibori, Masahiro.

In: European Journal of Pharmacology, Vol. 558, No. 1-3, 08.03.2007, p. 179-184.

Research output: Contribution to journalArticle

@article{dc1830164b934441b4b1343b604255ca,
title = "Effect of amodiaquine, a histamine N-methyltransferase inhibitor, on, Propionibacterium acnes and lipopolysaccharide-induced hepatitis in mice",
abstract = "We examined whether treatment with amodiaquine, a potent inhibitor of histamine N-methyltransferase protects mice from Propionibacterium acnes (P. acnes)-primed and lipopolysaccharide (LPS)-induced hepatitis. The subcutaneous injection of amodiaquine (2 and 5 mg/kg) significantly increased the histamine levels in the liver in comparison to saline treated mice. Pretreatment with amodiaquine also improved the survival rate of the hepatitis mice, and this improvement was partially associated with the decrease in serum levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT). Amodiaquine partially suppressed increases of tumor necrosis factor (TNF)-α in the serum and TNF-α mRNA expression in the liver, whereas the expression of interleukin (IL)-18, interferon (IFN)-γ and IL-12 in the liver was not changed by amodiaquine treatment. In conclusion, the present findings suggested that the elevation of endogenous histamine by amodiaquine may thus play a protective role through the regulation of TNF-α production in endotoxin-induced hepatic injury mice.",
keywords = "Amodiaquine, Hepatitis, Lipopolysaccharide, Propionibacterium acnes",
author = "Akira Yokoyama and Shuji Mori and Takahashi, {Hideo K.} and Toru Kanke and Hidenori Wake and Masahiro Nishibori",
year = "2007",
month = "3",
day = "8",
doi = "10.1016/j.ejphar.2006.11.033",
language = "English",
volume = "558",
pages = "179--184",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1-3",

}

TY - JOUR

T1 - Effect of amodiaquine, a histamine N-methyltransferase inhibitor, on, Propionibacterium acnes and lipopolysaccharide-induced hepatitis in mice

AU - Yokoyama, Akira

AU - Mori, Shuji

AU - Takahashi, Hideo K.

AU - Kanke, Toru

AU - Wake, Hidenori

AU - Nishibori, Masahiro

PY - 2007/3/8

Y1 - 2007/3/8

N2 - We examined whether treatment with amodiaquine, a potent inhibitor of histamine N-methyltransferase protects mice from Propionibacterium acnes (P. acnes)-primed and lipopolysaccharide (LPS)-induced hepatitis. The subcutaneous injection of amodiaquine (2 and 5 mg/kg) significantly increased the histamine levels in the liver in comparison to saline treated mice. Pretreatment with amodiaquine also improved the survival rate of the hepatitis mice, and this improvement was partially associated with the decrease in serum levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT). Amodiaquine partially suppressed increases of tumor necrosis factor (TNF)-α in the serum and TNF-α mRNA expression in the liver, whereas the expression of interleukin (IL)-18, interferon (IFN)-γ and IL-12 in the liver was not changed by amodiaquine treatment. In conclusion, the present findings suggested that the elevation of endogenous histamine by amodiaquine may thus play a protective role through the regulation of TNF-α production in endotoxin-induced hepatic injury mice.

AB - We examined whether treatment with amodiaquine, a potent inhibitor of histamine N-methyltransferase protects mice from Propionibacterium acnes (P. acnes)-primed and lipopolysaccharide (LPS)-induced hepatitis. The subcutaneous injection of amodiaquine (2 and 5 mg/kg) significantly increased the histamine levels in the liver in comparison to saline treated mice. Pretreatment with amodiaquine also improved the survival rate of the hepatitis mice, and this improvement was partially associated with the decrease in serum levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT). Amodiaquine partially suppressed increases of tumor necrosis factor (TNF)-α in the serum and TNF-α mRNA expression in the liver, whereas the expression of interleukin (IL)-18, interferon (IFN)-γ and IL-12 in the liver was not changed by amodiaquine treatment. In conclusion, the present findings suggested that the elevation of endogenous histamine by amodiaquine may thus play a protective role through the regulation of TNF-α production in endotoxin-induced hepatic injury mice.

KW - Amodiaquine

KW - Hepatitis

KW - Lipopolysaccharide

KW - Propionibacterium acnes

UR - http://www.scopus.com/inward/record.url?scp=33847326203&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847326203&partnerID=8YFLogxK

U2 - 10.1016/j.ejphar.2006.11.033

DO - 10.1016/j.ejphar.2006.11.033

M3 - Article

C2 - 17222819

AN - SCOPUS:33847326203

VL - 558

SP - 179

EP - 184

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1-3

ER -